+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Implantable Glaucoma Device Market - Global Forecast 2026-2032

  • Report

  • 193 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6148396
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Implantable Glaucoma Device Market is projected to reach USD 1.56 Billion in 2026. It is expected to continue growing at a CAGR of 6.68%, reaching USD 2.30 Billion by 2032.

Implantable Glaucoma Devices: Executive Overview

Implantable glaucoma devices are designed to reduce intraocular pressure by improving aqueous humor drainage or creating controlled pathways for fluid outflow. They are used primarily when topical medicines, laser procedures, or conventional surgery do not provide sufficient pressure control or are poorly tolerated. Clinical decision-making depends on glaucoma type and severity, prior procedures, ocular anatomy, medication adherence, and the patient’s risk of visual-field loss.

How Surgical Practice Is Evolving

The treatment landscape is shifting toward more individualized, less invasive approaches that seek to balance pressure reduction with recovery time and complication risk. Device selection is increasingly considered alongside medication burden, conjunctival scarring, cataract status, and the need for future surgical options. Adoption is also influenced by surgeon training, operating-room capability, reimbursement policy, post-operative monitoring, and the availability of long-term clinical evidence.

Artificial Intelligence and the Glaucoma Care Pathway

Artificial intelligence is contributing to glaucoma care through automated optic-nerve assessment, retinal imaging analysis, visual-field interpretation, and risk stratification. These tools may support earlier referral, more consistent follow-up, and identification of patients whose pressure control or structural damage warrants procedural review. Their clinical value depends on representative training data, external validation, transparent performance measures, interoperability with ophthalmic records, and clinician oversight; they should complement rather than replace specialist judgment.

Regional Dynamics Across Glaucoma Care Systems

North America is characterized by comparatively mature specialist infrastructure, established surgical pathways, and strong attention to evidence, reimbursement, and post-operative surveillance. Europe combines advanced ophthalmic services with country-level differences in health technology assessment, procurement, and access. Asia-Pacific includes high-volume clinical systems alongside substantial urban-rural variation, creating demand for scalable diagnosis and follow-up models. Latin America faces uneven access to specialists, diagnostic equipment, and reimbursement, while local referral networks strongly influence treatment. In the Middle East, investment in specialist centers and technology is accompanied by workforce and access differences between countries. Africa continues to face major gaps in screening, diagnosis, surgical capacity, and continuity of care, making training and adaptable delivery models especially important.

Group-Level Signals: ASEAN, BRICS, EU, G7, GCC, and NATO

ASEAN markets differ considerably in specialist density, public coverage, and the availability of advanced ophthalmic surgery, favoring regional training and referral partnerships. BRICS economies combine large patient populations with varied reimbursement, manufacturing, and clinical research capabilities, but access is uneven within and between members. The European Union benefits from cross-border scientific collaboration while retaining national differences in procurement and reimbursement. G7 systems generally have strong research and specialist capacity, with persistent concerns around affordability, waiting times, and equitable access. GCC countries are strengthening tertiary healthcare and specialist infrastructure, although dependence on imported expertise and technology remains relevant. NATO members span diverse health systems; the most transferable opportunities involve resilient supply chains, standardized training, and digitally supported specialist networks rather than a single uniform care model.

Country-Level Considerations for Device Adoption

Australia and Canada must address geographic dispersion and specialist access alongside evidence-based reimbursement. Brazil, Mexico, India, China, and Russia combine substantial clinical need with pronounced regional differences in healthcare capacity, procurement, and affordability. France, Germany, Italy, Spain, and the United Kingdom have established ophthalmology services, but adoption is shaped by national or regional assessment, hospital purchasing, surgical training, and waiting-list management. Japan and South Korea have sophisticated diagnostic and surgical capabilities, with demand influenced by aging populations, clinical evidence, and workflow efficiency. Across the United States, access is supported by extensive specialist infrastructure, while payer policy, procedure selection, outcomes documentation, and disparities between communities remain important considerations.

Priorities for Industry Leaders in Implantable Glaucoma Devices

Industry leaders should prioritize robust comparative evidence that reports pressure control, medication reduction, visual outcomes, adverse events, reintervention, and durability across relevant glaucoma subgroups. Product development should emphasize predictable implantation, compatibility with varied ocular anatomy, manageable learning curves, and efficient post-operative monitoring. Access strategies should align with local reimbursement and procurement requirements, while clinician education should include simulation, patient selection, complication management, and long-term follow-up. Responsible use of artificial intelligence requires clinical validation, data governance, explainability, cybersecurity, and clear accountability. Partnerships with hospitals, professional societies, and public-health systems can improve referral pathways and support equitable implementation.

Methodology for the Executive Summary

This executive summary is framed from the supplied market topic and the specified geographic and group coverage. It uses established clinical principles concerning glaucoma management, implantable drainage procedures, ophthalmic diagnostics, healthcare delivery, and artificial intelligence. The analysis is qualitative and does not provide market estimates, market sizing, market shares, forecasts, or company-specific claims. Regional, group, and country observations are presented as contextual considerations and should be validated against current regulatory decisions, reimbursement rules, clinical guidelines, peer-reviewed evidence, and local health-system data before operational use.

Conclusion: Evidence-Led Expansion of Glaucoma Care

Implantable glaucoma devices occupy an important role in pressure management when conventional therapies are insufficient, unsuitable, or burdensome. Their broader clinical value will depend on appropriate patient selection, dependable evidence, surgeon capability, longitudinal monitoring, and equitable access rather than device availability alone. Regional health-system differences, artificial-intelligence governance, reimbursement conditions, and workforce capacity should therefore be addressed together. Leaders that combine clinically meaningful outcomes with practical implementation support will be better positioned to improve glaucoma care responsibly.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Implantable Glaucoma Device Market, by Product Type
7.1. Introduction
7.2. Drainage Devices
7.2.1. Non-Valved Implants
7.2.1.1. Baerveldt Implant
7.2.1.2. Molteno Implant
7.2.2. Valved Implants
7.3. Microinvasive Glaucoma Surgery Devices
7.3.1. Subconjunctival Devices
7.3.1.1. PreserFlo MicroShunt
7.3.1.2. XEN Gel Stent
7.3.2. Suprachoroidal Stents
7.3.3. Trabecular Micro-Bypass Stents
7.3.3.1. Hydrus Microstent
7.3.3.2. IStent
8. Implantable Glaucoma Device Market, by End User
8.1. Introduction
8.2. Ambulatory Surgical Centers
8.2.1. Hospital Owned Centers
8.2.2. Independent Centers
8.3. Hospitals
8.3.1. Private Hospitals
8.3.2. Public Hospitals
8.4. Ophthalmology Clinics
8.4.1. Multi-Specialty Clinics
8.4.2. Standalone Clinics
9. Implantable Glaucoma Device Market, by Distribution Channel
9.1. Introduction
9.2. Direct Sales
9.3. Distributors
9.3.1. Medical Device Distributors
9.3.2. Third Party Distributors
10. Implantable Glaucoma Device Market, by Region
10.1. Introduction
10.2. Asia-Pacific
10.3. North America
10.4. Latin America
10.5. Europe
10.6. Middle East
10.7. Africa
11. Implantable Glaucoma Device Market, by Group
11.1. Introduction
11.2. ASEAN
11.3. GCC
11.4. European Union
11.5. BRICS
11.6. G7
11.7. NATO
12. Implantable Glaucoma Device Market, by Country
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. United Kingdom
12.7. Germany
12.8. France
12.9. Russia
12.10. Italy
12.11. Spain
12.12. China
12.13. India
12.14. Japan
12.15. Australia
12.16. South Korea
13. Competitive Landscape
13.1. Market Share Analysis, 2025
13.2. Market Concentration Analysis, 2025
13.2.1. Concentration Ratio (CR)
13.2.2. Herfindahl Hirschman Index (HHI)
13.3. Recent Developments & Impact Analysis, 2025
13.4. Product Portfolio Analysis, 2025
13.5. Benchmarking Analysis, 2025
14. Company Profiles
14.1. AbbVie Inc
14.2. Alcon Inc
14.3. Bausch + Lomb Corporation
14.4. Beaver-Visitec International Limited
14.5. Carl Zeiss Meditec AG
14.6. Glaukos Corporation
14.7. Implandata Ophthalmic Products GmbH
14.8. iStar Medical SA
14.9. Johnson & Johnson
14.10. MicroOptx, Inc.
14.11. New World Medical, Inc.
14.12. Santen Pharmaceutical Co., Ltd.
14.13. STAAR Surgical Company
15. Key Experts
LIST OF FIGURES
FIGURE 1. Global Implantable Glaucoma Device Market, Years Considered for the Study
FIGURE 2. Global Implantable Glaucoma Device Market, Research Design
FIGURE 3. Global Implantable Glaucoma Device Market, Research Framework
FIGURE 4. Global Implantable Glaucoma Device Market, Data Triangulation
FIGURE 5. Global Implantable Glaucoma Device Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Implantable Glaucoma Device Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Implantable Glaucoma Device Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Implantable Glaucoma Device Market Size, by End User, 2025 vs 2032 (%)
FIGURE 9. Global Implantable Glaucoma Device Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Implantable Glaucoma Device Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 11. Global Implantable Glaucoma Device Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Implantable Glaucoma Device Market Size, by Region, 2025 vs 2032 (%)
FIGURE 13. Global Implantable Glaucoma Device Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Implantable Glaucoma Device Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 15. Global Implantable Glaucoma Device Market Size, by Country, 2025 vs 2032 (%)
FIGURE 16. Global Implantable Glaucoma Device Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Implantable Glaucoma Device Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Implantable Glaucoma Device Market Segmentation & Coverage
TABLE 2. Global Implantable Glaucoma Device Market Size, 2017-2032 (USD Million)
TABLE 3. Global Implantable Glaucoma Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Drainage Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Drainage Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Drainage Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Non-Valved Implants Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Non-Valved Implants Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Non-Valved Implants Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Baerveldt Implant Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Baerveldt Implant Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Baerveldt Implant Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Molteno Implant Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Molteno Implant Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Molteno Implant Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Valved Implants Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Valved Implants Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Valved Implants Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Microinvasive Glaucoma Surgery Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Microinvasive Glaucoma Surgery Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Microinvasive Glaucoma Surgery Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Subconjunctival Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Subconjunctival Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Subconjunctival Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global PreserFlo MicroShunt Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global PreserFlo MicroShunt Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global PreserFlo MicroShunt Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global XEN Gel Stent Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global XEN Gel Stent Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global XEN Gel Stent Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Suprachoroidal Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Suprachoroidal Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Suprachoroidal Stents Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Trabecular Micro-Bypass Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Trabecular Micro-Bypass Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Trabecular Micro-Bypass Stents Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Hydrus Microstent Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Hydrus Microstent Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Hydrus Microstent Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global IStent Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global IStent Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global IStent Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Implantable Glaucoma Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 44. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Hospital Owned Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Hospital Owned Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Hospital Owned Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Independent Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Independent Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Independent Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Private Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Private Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Private Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Public Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Public Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Public Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Ophthalmology Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Ophthalmology Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Ophthalmology Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Multi-Specialty Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Multi-Specialty Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Multi-Specialty Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Standalone Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Standalone Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Standalone Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Implantable Glaucoma Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 72. Global Direct Sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Direct Sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Direct Sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Distributors Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Distributors Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Distributors Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Medical Device Distributors Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Medical Device Distributors Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Medical Device Distributors Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Third Party Distributors Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Third Party Distributors Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Third Party Distributors Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Implantable Glaucoma Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Asia-Pacific Implantable Glaucoma Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Asia-Pacific Implantable Glaucoma Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 87. Asia-Pacific Implantable Glaucoma Device Market Size, by Drainage Devices, 2017-2032 (USD Million)
TABLE 88. Asia-Pacific Implantable Glaucoma Device Market Size, by Non-Valved Implants, 2017-2032 (USD Million)
TABLE 89. Asia-Pacific Implantable Glaucoma Device Market Size, by Microinvasive Glaucoma Surgery Devices, 2017-2032 (USD Million)
TABLE 90. Asia-Pacific Implantable Glaucoma Device Market Size, by Subconjunctival Devices, 2017-2032 (USD Million)
TABLE 91. Asia-Pacific Implantable Glaucoma Device Market Size, by Trabecular Micro-Bypass Stents, 2017-2032 (USD Million)
TABLE 92. Asia-Pacific Implantable Glaucoma Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 93. Asia-Pacific Implantable Glaucoma Device Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 94. Asia-Pacific Implantable Glaucoma Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 95. Asia-Pacific Implantable Glaucoma Device Market Size, by Ophthalmology Clinics, 2017-2032 (USD Million)
TABLE 96. Asia-Pacific Implantable Glaucoma Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 97. Asia-Pacific Implantable Glaucoma Device Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 98. North America Implantable Glaucoma Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. North America Implantable Glaucoma Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 100. North America Implantable Glaucoma Device Market Size, by Drainage Devices, 2017-2032 (USD Million)
TABLE 101. North America Implantable Glaucoma Device Market Size, by Non-Valved Implants, 2017-2032 (USD Million)
TABLE 102. North America Implantable Glaucoma Device Market Size, by Microinvasive Glaucoma Surgery Devices, 2017-2032 (USD Million)
TABLE 103. North America Implantable Glaucoma Device Market Size, by Subconjunctival Devices, 2017-2032 (USD Million)
TABLE 104. North America Implantable Glaucoma Device Market Size, by Trabecular Micro-Bypass Stents, 2017-2032 (USD Million)
TABLE 105. North America Implantable Glaucoma Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 106. North America Implantable Glaucoma Device Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 107. North America Implantable Glaucoma Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 108. North America Implantable Glaucoma Device Market Size, by Ophthalmology Clinics, 2017-2032 (USD Million)
TABLE 109. North America Implantable Glaucoma Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 110. North America Implantable Glaucoma Device Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 111. Latin America Implantable Glaucoma Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 112. Latin America Implantable Glaucoma Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 113. Latin America Implantable Glaucoma Device Market Size, by Drainage Devices, 2017-2032 (USD Million)
TABLE 114. Latin America Implantable Glaucoma Device Market Size, by Non-Valved Implants, 2017-2032 (USD Million)
TABLE 115. Latin America Implantable Glaucoma Device Market Size, by Microinvasive Glaucoma Surgery Devices, 2017-2032 (USD Million)
TABLE 116. Latin America Implantable Glaucoma Device Market Size, by Subconjunctival Devices, 2017-2032 (USD Million)
TABLE 117. Latin America Implantable Glaucoma Device Market Size, by Trabecular Micro-Bypass Stents, 2017-2032 (USD Million)
TABLE 118. Latin America Implantable Glaucoma Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 119. Latin America Implantable Glaucoma Device Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 120. Latin America Implantable Glaucoma Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 121. Latin America Implantable Glaucoma Device Market Size, by Ophthalmology Clinics, 2017-2032 (USD Million)
TABLE 122. Latin America Implantable Glaucoma Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 123. Latin America Implantable Glaucoma Device Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 124. Europe Implantable Glaucoma Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 125. Europe Implantable Glaucoma Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 126. Europe Implantable Glaucoma Device Market Size, by Drainage Devices, 2017-2032 (USD Million)
TABLE 127. Europe Implantable Glaucoma Device Market Size, by Non-Valved Implants, 2017-2032 (USD Million)
TABLE 128. Europe Implantable Glaucoma Device Market Size, by Microinvasive Glaucoma Surgery Devices, 2017-2032 (USD Million)
TABLE 129. Europe Implantable Glaucoma Device Market Size, by Subconjunctival Devices, 2017-2032 (USD Million)
TABLE 130. Europe Implantable Glaucoma Device Market Size, by Trabecular Micro-Bypass Stents, 2017-2032 (USD Million)
TABLE 131. Europe Implantable Glaucoma Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 132. Europe Implantable Glaucoma Device Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 133. Europe Implantable Glaucoma Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 134. Europe Implantable Glaucoma Device Market Size, by Ophthalmology Clinics, 2017-2032 (USD Million)
TABLE 135. Europe Implantable Glaucoma Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 136. Europe Implantable Glaucoma Device Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 137. Middle East Implantable Glaucoma Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 138. Middle East Implantable Glaucoma Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 139. Middle East Implantable Glaucoma Device Market Size, by Drainage Devices, 2017-2032 (USD Million)
TABLE 140. Middle East Implantable Glaucoma Device Market Size, by Non-Valved Implants, 2017-2032 (USD Million)
TABLE 141. Middle East Implantable Glaucoma Device Market Size, by Microinvasive Glaucoma Surgery Devices, 2017-2032 (USD Million)
TABLE 142. Middle East Implantable Glaucoma Device Market Size, by Subconjunctival Devices, 2017-2032 (USD Million)
TABLE 143. Middle East Implantable Glaucoma Device Market Size, by Trabecular Micro-Bypass Stents, 2017-2032 (USD Million)
TABLE 144. Middle East Implantable Glaucoma Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 145. Middle East Implantable Glaucoma Device Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 146. Middle East Implantable Glaucoma Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 147. Middle East Implantable Glaucoma Device Market Size, by Ophthalmology Clinics, 2017-2032 (USD Million)
TABLE 148. Middle East Implantable Glaucoma Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 149. Middle East Implantable Glaucoma Device Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 150. Africa Implantable Glaucoma Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 151. Africa Implantable Glaucoma Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 152. Africa Implantable Glaucoma Device Market Size, by Drainage Devices, 2017-2032 (USD Million)
TABLE 153. Africa Implantable Glaucoma Device Market Size, by Non-Valved Implants, 2017-2032 (USD Million)
TABLE 154. Africa Implantable Glaucoma Device Market Size, by Microinvasive Glaucoma Surgery Devices, 2017-2032 (USD Million)
TABLE 155. Africa Implantable Glaucoma Device Market Size, by Subconjunctival Devices, 2017-2032 (USD Million)
TABLE 156. Africa Implantable Glaucoma Device Market Size, by Trabecular Micro-Bypass Stents, 2017-2032 (USD Million)
TABLE 157. Africa Implantable Glaucoma Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 158. Africa Implantable Glaucoma Device Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 159. Africa Implantable Glaucoma Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 160. Africa Implantable Glaucoma Device Market Size, by Ophthalmology Clinics, 2017-2032 (USD Million)
TABLE 161. Africa Implantable Glaucoma Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 162. Africa Implantable Glaucoma Device Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 163. Global Implantable Glaucoma Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 164. ASEAN Implantable Glaucoma Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 165. ASEAN Implantable Glaucoma Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 166. ASEAN Implantable Glaucoma Device Market Size, by Drainage Devices, 2017-2032 (USD Million)
TABLE 167. ASEAN Implantable Glaucoma Device Market Size, by Non-Valved Implants, 2017-2032 (USD Million)
TABLE 168. ASEAN Implantable Glaucoma Device Market Size, by Microinvasive Glaucoma Surgery Devices, 2017-2032 (USD Million)
TABLE 169. ASEAN Implantable Glaucoma Device Market Size, by Subconjunctival Devices, 2017-2032 (USD Million)
TABLE 170. ASEAN Implantable Glaucoma Device Market Size, by Trabecular Micro-Bypass Stents, 2017-2032 (USD Million)
TABLE 171. ASEAN Implantable Glaucoma Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 172. ASEAN Implantable Glaucoma Device Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 173. ASEAN Implantable Glaucoma Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 174. ASEAN Implantable Glaucoma Device Market Size, by Ophthalmology Clinics, 2017-2032 (USD Million)
TABLE 175. ASEAN Implantable Glaucoma Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 176. ASEAN Implantable Glaucoma Device Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 177. GCC Implantable Glaucoma Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 178. GCC Implantable Glaucoma Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 179. GCC Implantable Glaucoma Device Market Size, by Drainage Devices, 2017-2032 (USD Million)
TABLE 180. GCC Implantable Glaucoma Device Market Size, by Non-Valved Implants, 2017-2032 (USD Million)
TABLE 181. GCC Implantable Glaucoma Device Market Size, by Microinvasive Glaucoma Surgery Devices, 2017-2032 (USD Million)
TABLE 182. GCC Implantable Glaucoma Device Market Size, by Subconjunctival Devices, 2017-2032 (USD Million)
TABLE 183. GCC Implantable Glaucoma Device Market Size, by Trabecular Micro-Bypass Stents, 2017-2032 (USD Million)
TABLE 184. GCC Implantable Glaucoma Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 185. GCC Implantable Glaucoma Device Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 186. GCC Implantable Glaucoma Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 187. GCC Implantable Glaucoma Device Market Size, by Ophthalmology Clinics, 2017-2032 (USD Million)
TABLE 188. GCC Implantable Glaucoma Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 189. GCC Implantable Glaucoma Device Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 190. European Union Implantable Glaucoma Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 191. European Union Implantable Glaucoma Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 192. European Union Implantable Glaucoma Device Market Size, by Drainage Devices, 2017-2032 (USD Million)
TABLE 193. European Union Implantable Glaucoma Device Market Size, by Non-Valved Implants, 2017-2032 (USD Million)
TABLE 194. European Union Implantable Glaucoma Device Market Size, by Microinvasive Glaucoma Surgery Devices, 2017-2032 (USD Million)
TABLE 195. European Union Implantable Glaucoma Device Market Size, by Subconjunctival Devices, 2017-2032 (USD Million)
TABLE 196. European Union Implantable Glaucoma Device Market Size, by Trabecular Micro-Bypass Stents, 2017-2032 (USD Million)
TABLE 197. European Union Implantable Glaucoma Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 198. European Union Implantable Glaucoma Device Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 199. European Union Implantable Glaucoma Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 200. European Union Implantable Glaucoma Device Market Size, by Ophthalmology Clinics, 2017-2032 (USD Million)
TABLE 201. European Union Implantable Glaucoma Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 202. European Union Implantable Glaucoma Device Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 203. BRICS Implantable Glaucoma Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 204. BRICS Implantable Glaucoma Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 205. BRICS Implantable Glaucoma Device Market Size, by Drainage Devices, 2017-2032 (USD Million)
TABLE 206. BRICS Implantable Glaucoma Device Market Size, by Non-Valved Implants, 2017-2032 (USD Million)
TABLE 207. BRICS Implantable Glaucoma Device Market Size, by Microinvasive Glaucoma Surgery Devices, 2017-2032 (USD Million)
TABLE 208. BRICS Implantable Glaucoma Device Market Size, by Subconjunctival Devices, 2017-2032 (USD Million)
TABLE 209. BRICS Implantable Glaucoma Device Market Size, by Trabecular Micro-Bypass Stents, 2017-2032 (USD Million)
TABLE 210. BRICS Implantable Glaucoma Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 211. BRICS Implantable Glaucoma Device Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 212. BRICS Implantable Glaucoma Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 213. BRICS Implantable Glaucoma Device Market Size, by Ophthalmology Clinics, 2017-2032 (USD Million)
TABLE 214. BRICS Implantable Glaucoma Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 215. BRICS Implantable Glaucoma Device Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 216. G7 Implantable Glaucoma Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 217. G7 Implantable Glaucoma Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 218. G7 Implantable Glaucoma Device Market Size, by Drainage Devices, 2017-2032 (USD Million)
TABLE 219. G7 Implantable Glaucoma Device Market Size, by Non-Valved Implants, 2017-2032 (USD Million)
TABLE 220. G7 Implantable Glaucoma Device Market Size, by Microinvasive Glaucoma Surgery Devices, 2017-2032 (USD Million)
TABLE 221. G7 Implantable Glaucoma Device Market Size, by Subconjunctival Devices, 2017-2032 (USD Million)
TABLE 222. G7 Implantable Glaucoma Device Market Size, by Trabecular Micro-Bypass Stents, 2017-2032 (USD Million)
TABLE 223. G7 Implantable Glaucoma Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 224. G7 Implantable Glaucoma Device Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 225. G7 Implantable Glaucoma Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 226. G7 Implantable Glaucoma Device Market Size, by Ophthalmology Clinics, 2017-2032 (USD Million)
TABLE 227. G7 Implantable Glaucoma Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 228. G7 Implantable Glaucoma Device Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 229. NATO Implantable Glaucoma Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 230. NATO Implantable Glaucoma Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 231. NATO Implantable Glaucoma Device Market Size, by Drainage Devices, 2017-2032 (USD Million)
TABLE 232. NATO Implantable Glaucoma Device Market Size, by Non-Valved Implants, 2017-2032 (USD Million)
TABLE 233. NATO Implantable Glaucoma Device Market Size, by Microinvasive Glaucoma Surgery Devices, 2017-2032 (USD Million)
TABLE 234. NATO Implantable Glaucoma Device Market Size, by Subconjunctival Devices, 2017-2032 (USD Million)
TABLE 235. NATO Implantable Glaucoma Device Market Size, by Trabecular Micro-Bypass Stents, 2017-2032 (USD Million)
TABLE 236. NATO Implantable Glaucoma Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 237. NATO Implantable Glaucoma Device Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 238. NATO Implantable Glaucoma Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 239. NATO Implantable Glaucoma Device Market Size, by Ophthalmology Clinics, 2017-2032 (USD Million)
TABLE 240. NATO Implantable Glaucoma Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 241. NATO Implantable Glaucoma Device Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 242. Global Implantable Glaucoma Device Market Size, by Country, 2017-2032 (USD Million)
TABLE 243. United States Implantable Glaucoma Device Market Size, 2017-2032 (USD Million)
TABLE 244. United States Implantable Glaucoma Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 245. United States Implantable Glaucoma Device Market Size, by Drainage Devices, 2017-2032 (USD Million)
TABLE 246. United States Implantable Glaucoma Device Market Size, by Non-Valved Implants, 2017-2032 (USD Million)
TABLE 247. United States Implantable Glaucoma Device Market Size, by Microinvasive Glaucoma Surgery Devices, 2017-2032 (USD Million)
TABLE 248. United States Implantable Glaucoma Device Market Size, by Subconjunctival Devices, 2017-2032 (USD Million)
TABLE 249. United States Implantable Glaucoma Device Market Size, by Trabecular Micro-Bypass Stents, 2017-2032 (USD Million)
TABLE 250. United States Implantable Glaucoma Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 251. United States Implantable Glaucoma Device Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 252. United States Implantable Glaucoma Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 253. United States Implantable Glaucoma Device Market Size, by Ophthalmology Clinics, 2017-2032 (USD Million)
TABLE 254. United States Implantable Glaucoma Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 255. United States Implantable Glaucoma Device Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 256. Canada Implantable Glaucoma Device Market Size, 2017-2032 (USD Million)
TABLE 257. Canada Implantable Glaucoma Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 258. Canada Implantable Glaucoma Device Market Size, by Drainage Devices, 2017-2032 (USD Million)
TABLE 259. Canada Implantable Glaucoma Device Market Size, by Non-Valved Implants, 2017-2032 (USD Million)
TABLE 260. Canada Implantable Glaucoma Device Market Size, by Microinvasive Glaucoma Surgery Devices, 2017-2032 (USD Million)
TABLE 261. Canada Implantable Glaucoma Device Market Size, by Subconjunctival Devices, 2017-2032 (USD Million)
TABLE 262. Canada Implantable Glaucoma Device Market Size, by Trabecular Micro-Bypass Stents, 2017-2032 (USD Million)
TABLE 263. Canada Implantable Glaucoma Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 264. Canada Implantable Glaucoma Device Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 265. Canada Implantable Glaucoma Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 266. Canada Implantable Glaucoma Device Market Size, by Ophthalmology Clinics, 2017-2032 (USD Million)
TABLE 267. Canada Implantable Glaucoma Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 268. Canada Implantable Glaucoma Device Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 269. Mexico Implantable Glaucoma Device Market Size, 2017-2032 (USD Million)
TABLE 270. Mexico Implantable Glaucoma Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 271. Mexico Implantable Glaucoma Device Market Size, by Drainage Devices, 2017-2032 (USD Million)
TABLE 272. Mexico Implantable Glaucoma Device Market Size, by Non-Valved Implants, 2017-2032 (USD Million)
TABLE 273. Mexico Implantable Glaucoma Device Market Size, by Microinvasive Glaucoma Surgery Devices, 2017-2032 (USD Million)
TABLE 274. Mexico Implantable Glaucoma Device Market Size, by Subconjunctival Devices, 2017-2032 (USD Million)
TABLE 275. Mexico Implantable Glaucoma Device Market Size, by Trabecular Micro-Bypass Stents, 2017-2032 (USD Million)
TABLE 276. Mexico Implantable Glaucoma Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 277. Mexico Implantable Glaucoma Device Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 278. Mexico Implantable Glaucoma Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 279. Mexico Implantable Glaucoma Device Market Size, by Ophthalmology Clinics, 2017-2032 (USD Million)
TABLE 280. Mexico Implantable Glaucoma Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 281. Mexico Implantable Glaucoma Device Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 282. Brazil Implantable Glaucoma Device Market Size, 2017-2032 (USD Million)
TABLE 283. Brazil Implantable Glaucoma Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 284. Brazil Implantable Glaucoma Device Market Size, by Drainage Devices, 2017-2032 (USD Million)
TABLE 285. Brazil Implantable Glaucoma Device Market Size, by Non-Valved Implants, 2017-2032 (USD Million)
TABLE 286. Brazil Implantable Glaucoma Device Market Size, by Microinvasive Glaucoma Surgery Devices, 2017-2032 (USD Million)
TABLE 287. Brazil Implantable Glaucoma Device Market Size, by Subconjunctival Devices, 2017-2032 (USD Million)
TABLE 288. Brazil Implantable Glaucoma Device Market Size, by Trabecular Micro-Bypass Stents, 2017-2032 (USD Million)
TABLE 289. Brazil Implantable Glaucoma Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 290. Brazil Implantable Glaucoma Device Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 291. Brazil Implantable Glaucoma Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 292. Brazil Implantable Glaucoma Device Market Size, by Ophthalmology Clinics, 2017-2032 (USD Million)
TABLE 293. Brazil Implantable Glaucoma Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 294. Brazil Implantable Glaucoma Device Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 295. United Kingdom Implantable Glaucoma Device Market Size, 2017-2032 (USD Million)
TABLE 296. United Kingdom Implantable Glaucoma Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 297. United Kingdom Implantable Glaucoma Device Market Size, by Drainage Devices, 2017-2032 (USD Million)
TABLE 298. United Kingdom Implantable Glaucoma Device Market Size, by Non-Valved Implants, 2017-2032 (USD Million)
TABLE 299. United Kingdom Implantable Glaucoma Device Market Size, by Microinvasive Glaucoma Surgery Devices, 2017-2032 (USD Million)
TABLE 300. United Kingdom Implantable Glaucoma Device Market Size, by Subconjunctival Devices, 2017-2032 (USD Million)
TABLE 301. United Kingdom Implantable Glaucoma Device Market Size, by Trabecular Micro-Bypass Stents, 2017-2032 (USD Million)
TABLE 302. United Kingdom Implantable Glaucoma Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 303. United Kingdom Implantable Glaucoma Device Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 304. United Kingdom Implantable Glaucoma Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 305. United Kingdom Implantable Glaucoma Device Market Size, by Ophthalmology Clinics, 2017-2032 (USD Million)
TABLE 306. United Kingdom Implantable Glaucoma Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 307. United Kingdom Implantable Glaucoma Device Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 308. Germany Implantable Glaucoma Device Market Size, 2017-2032 (USD Million)
TABLE 309. Germany Implantable Glaucoma Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 310. Germany Implantable Glaucoma Device Market Size, by Drainage Devices, 2017-2032 (USD Million)
TABLE 311. Germany Implantable Glaucoma Device Market Size, by Non-Valved Implants, 2017-2032 (USD Million)
TABLE 312. Germany Implantable Glaucoma Device Market Size, by Microinvasive Glaucoma Surgery Devices, 2017-2032 (USD Million)
TABLE 313. Germany Implantable Glaucoma Device Market Size, by Subconjunctival Devices, 2017-2032 (USD Million)
TABLE 314. Germany Implantable Glaucoma Device Market Size, by Trabecular Micro-Bypass Stents, 2017-2032 (USD Million)
TABLE 315. Germany Implantable Glaucoma Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 316. Germany Implantable Glaucoma Device Market Size, by Ambulatory Surgical Centers, 2017-2032 (USD Million)
TABLE 317. Germany Implantable Glaucoma Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 318. Germany Implantable Glaucoma Device Market Size, by Ophthalmology Clinics, 2017-2032 (USD Million)
TABLE 319. Germany Implantable Glaucoma Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 320. Germany Implantable Glaucoma Device Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 321. France Implantable Glaucoma Device Market Size,

Companies Mentioned

  • AbbVie Inc
  • Alcon Inc
  • Bausch + Lomb Corporation
  • Beaver-Visitec International Limited
  • Carl Zeiss Meditec AG
  • Glaukos Corporation
  • Implandata Ophthalmic Products GmbH
  • iStar Medical SA
  • Johnson & Johnson
  • MicroOptx, Inc.
  • New World Medical, Inc.
  • Santen Pharmaceutical Co., Ltd.
  • STAAR Surgical Company